CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Curis Lifesciences Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Curis Lifesciences Ltd
Industrial Estate
Ahmedabad, Pf-23, Gidc Sanand - Ii
AHMEDABAD, 382110  India Ticker: CURISCURIS
Business Summary
Curis Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral Liquid, and Sterile Ophthalmic Ointments. The Company manufactures activities on loan license, Contract Manufacturing and Direct Export basis/Own Brand Marketing basis. Its products include general pharmaceutical tablets, general pharmaceutical capsules, general oral liquid, general external preparation, and sterile ophthalmic ointment. Its pharmaceutical tablets are solid dosage form of medication used for delivering active pharmaceutical ingredients. Its sterile ophthalmic ointment is a type of medication formulated for use in the eyes. Its oral liquid is versatile form of medication to be taken by mouth.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20253/31/2025-----

Industries
SIC Code Description
2834 Pharmaceutical preparations

General Information
Stock Exchange: NSE


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, November 17, 2025